Table 2.
Clinical characteristics of premature infants who were administered surfactant by the standard method.
| STANDARD, (n = 49) | |
|---|---|
| Duration of MV, hours (mean ± SD) | 217.6 ± 173 |
| Antenatal corticosteroids, n (%) | 26 (53.1) |
| Need for subsequent surfactant doses, n (%) | 12 (24.5) |
| Morbidity, n (%) | 43 (87.8) |
| Pneumothorax, n (%) | 9 (18.4) |
| BPD, n (%) | 22 (44.9) |
| NEC, n (%) | 9 (18.4) |
| IVH, n (%) | 27 (55.1) |
| IVH 3–4, n (%) | 13 (26.5) |
| PVL, n (%) | 3 (6.1) |
| PDA, n (%) | 12 (24.5) |
| Ventriculomegaly, n (%) | 12 (24.5) |
| Sepsis/probable sepsis, n (%) | 11 (23.4) |
| ROP, n (%) | 17 (56.7) |
| NICU, days, median (IQR) | 26 (7–43) |
| Deaths, n (%) | 18 (36.7) |
Continuous variables were expressed as: mean ± standard deviation; categorical variables: number (%); n: number; MV: mechanical ventilation; BPD: bronchopulmonary dysplasia; NEC: necrotizing enterocolitis; IVH: intraventricular hemorrhage; PVL: periventricular leukomalacia; PDA: patent ductus arteriosus; ROP: retinopathy of prematurity; NICU: Neonatal Intensive Care Unit; IQR: interquartile range.